{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:03:03Z","timestamp":1789722183830,"version":"4.0.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"DOI":"10.1007\/s12185-026-04279-y","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:32:57Z","timestamp":1789720377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dynamic nutritional changes between relapse and second allogeneic transplantation predict survival in acute leukemia"],"prefix":"10.1007","author":[{"given":"Kodai","family":"Hasegawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1884-4757","authenticated-orcid":false,"given":"Takuya","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Hagihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuki","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Nukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"issue":"2","key":"4279_CR1","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41409-019-0584-3","volume":"55","author":"NM Moukalled","year":"2020","unstructured":"Moukalled NM, Kharfan-Dabaja MA. What is the role of a second allogeneic hematopoietic cell transplant in relapsed acute myeloid leukemia? Bone Marrow Transplant. 2020;55(2):325\u201331.","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"4279_CR2","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/bmt.2015.186","volume":"50","author":"T Ruutu","year":"2015","unstructured":"Ruutu T, de Wreede LC, van Biezen A, Brand R, Mohty M, Dreger P, et al. Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT. Bone Marrow Transplant. 2015;50(12):1542\u201350.","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"4279_CR3","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/bjh.15973","volume":"186","author":"A Nagler","year":"2019","unstructured":"Nagler A, Labopin M, Dholaria B, Finke J, Brecht A, Schanz U, et al. Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation. Br J Haematol. 2019;186(5):767\u201376.","journal-title":"Br J Haematol"},{"issue":"1","key":"4279_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01060-4","volume":"14","author":"AK Schmalter","year":"2024","unstructured":"Schmalter AK, Ngoya M, Galimard JE, Bazarbachi A, Finke J, Kroger N, et al. Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients. Blood Cancer J. 2024;14(1):76.","journal-title":"Blood Cancer J"},{"issue":"8","key":"4279_CR5","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1038\/s41375-024-02318-3","volume":"38","author":"O Penack","year":"2024","unstructured":"Penack O, Abouqateb M, Peczynski C, Boreland W, Kroger N, Zeiser R, et al. How risky is a second allogeneic stem cell transplantation? Leukemia. 2024;38(8):1799\u2013807.","journal-title":"Leukemia"},{"issue":"7","key":"4279_CR6","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s00277-020-04089-0","volume":"99","author":"S Kaito","year":"2020","unstructured":"Kaito S, Wada A, Adachi H, Konuma R, Kishida Y, Nagata A, et al. Geriatric nutritional risk index as a useful prognostic factor in second allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2020;99(7):1655\u201365.","journal-title":"Ann Hematol"},{"key":"4279_CR7","doi-asserted-by":"crossref","unstructured":"Sadaga Y, Najima Y, Tachibana T, Harada K, Miyazaki T, Toya T, et al. Novel scoring system using geriatric nutritional risk index, C-reactive protein, and disease status predicts survival after second allogeneic stem cell transplantation. Transplant Cell Ther. 2026;32(4):480 e1\u2013e13.","DOI":"10.1016\/j.jtct.2025.11.042"},{"issue":"4","key":"4279_CR8","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/ajcn\/82.4.777","volume":"82","author":"O Bouillanne","year":"2005","unstructured":"Bouillanne O, Morineau G, Dupont C, Coulombel I, Vincent JP, Nicolis I, et al. Geriatric nutritional risk index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr. 2005;82(4):777\u201383.","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"4279_CR9","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106(8):2912\u20139.","journal-title":"Blood"},{"issue":"3","key":"4279_CR10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 2013;48(3):452\u20138.","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"4279_CR11","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00277-021-04736-0","volume":"101","author":"J Schaffrath","year":"2022","unstructured":"Schaffrath J, Diederichs T, Unverzagt S, Wass M, Glaser U, Weber T, et al. Correlation of nutrition-associated parameters with non-relapse mortality in allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2022;101(3):681\u201391.","journal-title":"Ann Hematol"},{"issue":"8","key":"4279_CR12","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.bbmt.2018.05.005","volume":"24","author":"R Shouval","year":"2018","unstructured":"Shouval R, de Jong CN, Fein J, Broers AEC, Danylesko I, Shimoni A, et al. Baseline renal function and albumin are powerful predictors for allogeneic transplantation-related mortality. Biol Blood Marrow Transplant. 2018;24(8):1685\u201391.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"4279_CR13","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.bbmt.2015.04.002","volume":"21","author":"JE Vaughn","year":"2015","unstructured":"Vaughn JE, Storer BE, Armand P, Raimondi R, Gibson C, Rambaldi A, et al. Design and validation of an augmented hematopoietic cell transplantation-comorbidity index comprising pretransplant ferritin, albumin, and platelet count for prediction of outcomes after allogeneic transplantation. Biol Blood Marrow Transplant. 2015;21(8):1418\u201324.","journal-title":"Biol Blood Marrow Transplant"},{"key":"4279_CR14","doi-asserted-by":"crossref","unstructured":"Miyazaki T, Tachibana T, Suzuki T, Izumi A, Fujimaki K, Sato S, et al. Pretransplantation inflammatory and nutritional status in elderly allogeneic hematopoietic stem cell transplantation: prognostic value of C-reactive protein-to-albumin ratio. Transplant Cell Ther. 2024;30(4):400 e1\u2013e9.","DOI":"10.1016\/j.jtct.2024.01.068"},{"issue":"6","key":"4279_CR15","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s12185-019-02647-5","volume":"109","author":"T Ando","year":"2019","unstructured":"Ando T, Fujisawa S, Teshigawara H, Ogusa E, Ishii Y, Miyashita K, et al. Impact of treatment-related weight changes from diagnosis to hematopoietic stem-cell transplantation on clinical outcome of acute myeloid leukemia. Int J Hematol. 2019;109(6):673\u201383.","journal-title":"Int J Hematol"},{"key":"4279_CR16","doi-asserted-by":"crossref","unstructured":"Reikvam H, Bruserud O, Hatfield KJ. Pretransplant systemic metabolic profiles in allogeneic hematopoietic stem cell transplant recipients\u2013identification of patient subsets with increased transplant-related mortality. Transplant Cell Ther. 2023;29(6):375 e1\u2013e14.","DOI":"10.1016\/j.jtct.2023.03.020"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04279-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-026-04279-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04279-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:33:00Z","timestamp":1789720380000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-026-04279-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":16,"alternative-id":["4279"],"URL":"https:\/\/doi.org\/10.1007\/s12185-026-04279-y","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"21 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Shin Fujisawa reports honoraria from Novartis and Otsuka. The remaining authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}